• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡相关代谢基因特征在肝细胞癌中的预后作用及潜在机制

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.

作者信息

Dai Tianxing, Li Jing, Lu Xu, Ye Linsen, Yu Haoyuan, Zhang Lele, Deng Mingbin, Zhu Shuguang, Liu Wei, Wang Guoying, Yang Yang

机构信息

Department of Hepatic Surgery and Liver Transplant Program, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.

Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

出版信息

Pharmgenomics Pers Med. 2021 Aug 3;14:927-945. doi: 10.2147/PGPM.S319524. eCollection 2021.

DOI:10.2147/PGPM.S319524
PMID:34377010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8349220/
Abstract

PURPOSE

Ferroptosis, as a novel regulated cell death form, has a close interaction with metabolism, which is largely unknown in cancer. In the present study, we conducted a comprehensive analysis of ferroptosis-related metabolic genes to delineate the metabolic signatures induced by ferroptosis and evaluate its prognostic significance in hepatocellular carcinoma (HCC).

METHODS

The ferroptosis-related metabolic genes (Fer-MRGs) were identified by correlation analyses with transcriptome data from The Cancer Genome Atlas and Gene Expression Omnibus. Then, univariate and the least absolute shrinkage and selection operator Cox regression analysis was used to establish a novel risk score model. Univariate and multivariate COX analyses were used to identify independent prognostic factors for overall survival (OS) of HCC, and a nomogram was developed. The Fer-MRGs' expression was further evaluated by quantitative real-time polymerase chain reaction in HCC.

RESULTS

A total of 77 metabolic genes were identified as Fer-MRGs, and 26 were found with prognostic values for OS of HCC. Then, a novel nine-gene (AKR1C3, ATIC, G6PD, GMPS, GNPDA1, IMPDH1, PRIM1, RRM2, and TXNRD1) risk score model was constructed. Survival analyses showed worse OS in high-risk patients both in the training and validation groups. The model was also identified as an independent prognostic factor for HCC, and a prognostic nomogram for OS was further established with superior discriminative capacity and prediction accuracy. Notably, close correlations were also identified between the risk score and the expression of immune checkpoint genes, immune subtypes of tumor, and susceptibility of HCC to chemotherapeutic agents. Finally, elevated expression of eight Fer-MRGs (except for IMPDH1) was further verified in 16 pairs of HCC tumor and adjacent tissues.

CONCLUSION

These results indicated the intense interaction between ferroptosis and metabolism, the significant role of ferroptosis-related MRGs, and the great potential of the novel risk score model for prognosis prediction in HCC.

摘要

目的

铁死亡作为一种新型的调控性细胞死亡形式,与代谢密切相关,而在癌症中这方面大多未知。在本研究中,我们对铁死亡相关代谢基因进行了全面分析,以描绘铁死亡诱导的代谢特征,并评估其在肝细胞癌(HCC)中的预后意义。

方法

通过与来自癌症基因组图谱和基因表达综合数据库的转录组数据进行相关性分析,鉴定出铁死亡相关代谢基因(Fer-MRGs)。然后,使用单变量和最小绝对收缩和选择算子Cox回归分析建立一个新的风险评分模型。采用单变量和多变量COX分析来确定HCC总生存期(OS)的独立预后因素,并绘制列线图。通过定量实时聚合酶链反应进一步评估HCC中Fer-MRGs的表达。

结果

共鉴定出77个代谢基因作为Fer-MRGs,其中26个对HCC的OS具有预后价值。随后,构建了一个新的九基因(AKR1C3、ATIC、G6PD、GMPS、GNPDA1、IMPDH1、PRIM1、RRM2和TXNRD1)风险评分模型。生存分析显示,训练组和验证组中的高危患者OS较差。该模型也被确定为HCC的独立预后因素,并进一步建立了具有卓越判别能力和预测准确性的OS预后列线图。值得注意的是,还发现风险评分与免疫检查点基因的表达、肿瘤的免疫亚型以及HCC对化疗药物的敏感性之间存在密切相关性。最后,在16对HCC肿瘤组织和癌旁组织中进一步验证了8个Fer-MRGs(IMPDH1除外)的表达升高。

结论

这些结果表明铁死亡与代谢之间存在紧密相互作用,铁死亡相关MRGs具有重要作用,以及新的风险评分模型在HCC预后预测方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/425eb99b7408/PGPM-14-927-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/b4fc9d0c3bea/PGPM-14-927-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/69ac93576c49/PGPM-14-927-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/c23ee36d20c3/PGPM-14-927-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/8e97861e2da6/PGPM-14-927-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/257c16c51b86/PGPM-14-927-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/425eb99b7408/PGPM-14-927-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/b4fc9d0c3bea/PGPM-14-927-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/69ac93576c49/PGPM-14-927-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/c23ee36d20c3/PGPM-14-927-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/8e97861e2da6/PGPM-14-927-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/257c16c51b86/PGPM-14-927-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb5/8349220/425eb99b7408/PGPM-14-927-g0007.jpg

相似文献

1
Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.铁死亡相关代谢基因特征在肝细胞癌中的预后作用及潜在机制
Pharmgenomics Pers Med. 2021 Aug 3;14:927-945. doi: 10.2147/PGPM.S319524. eCollection 2021.
2
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.一种新型代谢相关特征作为肝细胞癌潜在预后生物标志物
J Hepatocell Carcinoma. 2021 Mar 16;8:119-132. doi: 10.2147/JHC.S294108. eCollection 2021.
3
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.新型铁死亡相关基因签名可预测肝细胞癌患者的总生存期。
Int J Biol Sci. 2020 Jul 6;16(13):2430-2441. doi: 10.7150/ijbs.45050. eCollection 2020.
4
Comprehensive analysis of ferroptosis-related genes for clinical and biological significance in hepatocellular carcinoma.肝细胞癌中铁死亡相关基因的临床和生物学意义的综合分析
Discov Oncol. 2023 May 17;14(1):69. doi: 10.1007/s12672-023-00677-4.
5
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.构建铁死亡相关的九个长链非编码 RNA 标志物用于预测肝细胞癌的预后和免疫反应。
Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021.
6
Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.肝细胞癌中与铁死亡相关的枢纽基因:预后特征、免疫相关性及耐药性分析
Front Genet. 2022 Jul 22;13:907331. doi: 10.3389/fgene.2022.907331. eCollection 2022.
7
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.肝细胞癌铁死亡与缺氧联合预后特征的构建与验证
Front Mol Biosci. 2021 Dec 17;8:809672. doi: 10.3389/fmolb.2021.809672. eCollection 2021.
8
Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.肝细胞癌中铁死亡相关亚型的鉴定与验证及预测特征
Pharmgenomics Pers Med. 2023 Jan 26;16:39-58. doi: 10.2147/PGPM.S397892. eCollection 2023.
9
Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.用于预测肝细胞癌预后和免疫活性的包含mRNA和lncRNA的铁死亡相关特征模型的鉴定
Front Oncol. 2021 Sep 9;11:738477. doi: 10.3389/fonc.2021.738477. eCollection 2021.
10
Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study.基于八基因特征的预测模型用于评估肝细胞癌患者预后的开发与验证:一项生物信息学研究
Ann Transl Med. 2022 May;10(9):524. doi: 10.21037/atm-22-1934.

引用本文的文献

1
Unveiling the Therapeutic Potential of Targeting RRM2 in Hepatocellular Carcinoma: An Integrated In Silico and In Vitro Study.揭示靶向核糖核苷酸还原酶M2亚基在肝细胞癌中的治疗潜力:一项计算机模拟和体外实验相结合的研究
Funct Integr Genomics. 2025 Jun 10;25(1):123. doi: 10.1007/s10142-025-01630-0.
2
A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma.一种用于预测肝细胞癌预后、免疫特征及治疗反应的新型铁死亡相关特征。
PLoS One. 2025 Jun 4;20(6):e0322158. doi: 10.1371/journal.pone.0322158. eCollection 2025.
3
Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma.

本文引用的文献

1
Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌中p53信号通路三个核心基因的鉴定与验证
World J Surg Oncol. 2021 Mar 8;19(1):66. doi: 10.1186/s12957-021-02174-w.
2
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).TSP50 通过激活葡萄糖-6-磷酸脱氢酶(G6PD)促进肝细胞增殖和肿瘤形成。
Cell Prolif. 2021 Apr;54(4):e13015. doi: 10.1111/cpr.13015. Epub 2021 Feb 25.
3
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
用于肝细胞癌预后预测的五个坏死性凋亡相关长链非编码RNA特征的鉴定与验证
Heliyon. 2024 Sep 6;10(18):e37403. doi: 10.1016/j.heliyon.2024.e37403. eCollection 2024 Sep 30.
4
Life span-associated ferroptosis-related genes identification and validation for hepatocellular carcinoma patients as hepatitis B virus carriers.鉴定和验证与寿命相关的铁死亡相关基因在乙型肝炎病毒携带者的肝细胞癌患者中的作用。
J Clin Lab Anal. 2023 Jul;37(13-14):e24930. doi: 10.1002/jcla.24930. Epub 2023 Jul 18.
5
Regulation of ncRNAs involved with ferroptosis in various cancers.各种癌症中与铁死亡相关的非编码RNA的调控。
Front Genet. 2023 Mar 29;14:1136240. doi: 10.3389/fgene.2023.1136240. eCollection 2023.
6
Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma.鉴定一种与核苷酸代谢相关的特征以预测肝细胞癌的预后并指导患者治疗
Front Genet. 2023 Jan 4;13:1089291. doi: 10.3389/fgene.2022.1089291. eCollection 2022.
7
IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.IMPdh1,一种与泛癌和肝细胞癌肿瘤免疫微环境相关的预后生物标志物和免疫治疗靶点。
Front Immunol. 2022 Dec 22;13:983490. doi: 10.3389/fimmu.2022.983490. eCollection 2022.
8
All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis.全反式维甲酸通过调节铁死亡抑制肝癌细胞的恶性行为。
Genes Dis. 2022 May 5;9(6):1742-1756. doi: 10.1016/j.gendis.2022.04.011. eCollection 2022 Nov.
9
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.肝细胞癌治疗中靶向铁死亡的前景与机制
Front Mol Biosci. 2022 Aug 16;9:947208. doi: 10.3389/fmolb.2022.947208. eCollection 2022.
10
Effect of Supplementation With Selenium-Yeast on Muscle Antioxidant Activity, Meat Quality, Fatty Acids and Amino Acids in Goats.酵母硒添加对山羊肌肉抗氧化活性、肉质、脂肪酸和氨基酸的影响。
Front Vet Sci. 2022 Jan 25;8:813672. doi: 10.3389/fvets.2021.813672. eCollection 2021.
DNA 引发酶亚基 1 通过激活 AKT/mTOR 信号通路和 UBE2C 介导的 P53 泛素化作用,恶化了肝细胞癌的进展。
Cell Biosci. 2021 Feb 23;11(1):42. doi: 10.1186/s13578-021-00555-y.
4
Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma.嘌呤代谢关键基因作为肝细胞癌预后生物标志物的鉴定
Front Oncol. 2021 Jan 14;10:583053. doi: 10.3389/fonc.2020.583053. eCollection 2020.
5
Broadening horizons: the role of ferroptosis in cancer.拓宽视野:铁死亡在癌症中的作用。
Nat Rev Clin Oncol. 2021 May;18(5):280-296. doi: 10.1038/s41571-020-00462-0. Epub 2021 Jan 29.
6
Ferroptosis: mechanisms, biology and role in disease.铁死亡:机制、生物学及其在疾病中的作用
Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282. doi: 10.1038/s41580-020-00324-8. Epub 2021 Jan 25.
7
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
8
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.免疫与铁死亡相关生物标志物特征的综合分析以改善肝细胞癌的预后预测
Front Genet. 2020 Dec 18;11:614888. doi: 10.3389/fgene.2020.614888. eCollection 2020.
9
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer.核糖核苷酸还原酶M2亚基可抵御铁死亡,是肝癌的一种肿瘤生物标志物。
Cancer Cell Int. 2020 Dec 7;20(1):587. doi: 10.1186/s12935-020-01689-8.
10
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.利用单细胞分析技术了解肝癌肿瘤细胞异质性及其对免疫治疗的影响。
J Hepatol. 2021 Mar;74(3):700-715. doi: 10.1016/j.jhep.2020.11.036. Epub 2020 Nov 30.